Biovica International AB (publ) (STO:BIOVIC.B)
Sweden
· Delayed Price · Currency is SEK 0.8800
-0.0080 (-0.90%)
May 16, 2025, 3:52 PM CET
Biovica International AB Revenue
Biovica International AB had revenue of 2.26M SEK in the quarter ending January 31, 2025, with 110.33% growth. This brings the company's revenue in the last twelve months to 8.19M, up 17.59% year-over-year. In the fiscal year ending April 30, 2024, Biovica International AB had annual revenue of 7.30M with 39.99% growth.
Revenue (ttm)
8.19M
Revenue Growth
+17.59%
P/S Ratio
10.05
Revenue / Employee
315.04K
Employees
32
Market Cap
82.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2024 | 7.30M | 2.08M | 39.99% |
| Apr 30, 2023 | 5.21M | 113.00K | 2.22% |
| Apr 30, 2022 | 5.10M | -2.38M | -31.84% |
| Apr 30, 2021 | 7.48M | -2.20M | -22.71% |
| Apr 30, 2020 | 9.68M | -457.00K | -4.51% |
| Apr 30, 2019 | Pro | Pro | Pro |
| Apr 30, 2018 | Pro | Pro | Pro |
| Apr 30, 2017 | Pro | Pro | Pro |
| Apr 30, 2016 | Pro | Pro | Pro |
| Apr 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Medicover AB | 23.56B |
| Camurus AB | 2.04B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |
| Vitrolife AB | 3.61B |